Gilead’s revenue rises 17% driven by sales of coronavirus treatment remdesivir

by Raphael Stevens 28 October 2020, 23:52 199 Views

Remdesivir generated $873 million in sales during the third quarter, mostly in the U.S., the company said.

Tesla’s Autopilot a ‘distant second’ to GM’s Super Cruise system in Consumer Reports testing

Bed Bath & Beyond plans to scale back coupons in bid to boost profits

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

Gilead’s revenue rises 17% driven by sales of coronavirus treatment remdesivir

Tesla’s Autopilot a ‘distant second’ to GM’s Super Cruise system in Consumer Reports testing

Bed Bath & Beyond plans to scale back coupons in bid to boost profits

ITALIAN LANGUAGE

ENGLISH LANGUAGE